ARDD
2026
13th Aging Research and Drug Discovery Meeting
October 1–3, 2026
David Rubenstein Treehouse at Harvard University
20 Western Avenue, Allston, Massachusetts
20 Western Avenue, Allston, Massachusetts
The 13th Aging Research and Drug Discovery Meeting
Leaders in the aging and longevity field describe the latest progress in the molecular, cellular and organismal basis of aging and our search for interventions, and give their reports on the quest to extend the healthy lifespan of everyone on the planet.
3
conference days
2
parallel forums
107
confirmed participants
104
scheduled items
Current programme and updates · agingpharma.org/program2026
2
Venue
David Rubenstein Treehouse at Harvard University
20 Western Avenue, Allston, Massachusetts
20 Western Avenue, Allston, Massachusetts
Canopy Hall · 3/F
Main Track, all three days
Cedar Grove · 2/F
AI in Drug Discovery Forum, October 2 · Pet and Animal Longevity Forum and Virtual Cell in Time Forum, October 3
One Milestone
Poster sessions, October 1–3
Access, transit and accessibility information · agingpharma.org/location
5
Three days at a glance
October 1 · Thursday · Main Track
Canopy Hall, 3/F
08:00
Breakfast and registration
09:10
Chair Opening Introduction
10:00
Matching Clinical Trials of Therapeutics & Regulatory Mandates
10:50
Morning networking break
11:20
Clinical Trials in Diseases of Aging: From Evidence to New Therapeutics and Regulatory Pathways
12:00
Lunch break
13:00
AI & Clinical Trials in Healthspan
14:00
Healthspan in Leading Industries
15:00
Afternoon networking break and poster session
15:30
Aging Research and Pharma R&D Productivity
16:30
Clinical Healthspan Trials and Practice
17:30
From Healthspan Trials to Clinical Practice: Building the Path to Patient Access
18:10
Closing remarks
18:30
Open bar
October 2 · Friday · Main Track
Canopy Hall, 3/F
08:00
Breakfast and registration
09:00
Chair Opening Introduction
09:35
Pharma Chief Executive Panel
11:00
Morning networking break and group photo
11:30
New Technology Partnering & Licensing
12:30
Lunch break
14:50
Diseases as a Pathway to Longevity Therapeutics: Which age-related disease resembles aging most closely?
15:30
Afternoon networking break and poster session
16:00
Early Stage Investor Panel
16:40
Full-Stack and Growth Stage Investor Panel
18:40
Open bar
19:00
Special speaker event
6
October 2 · Friday · AI in Drug Discovery Forum
Cedar Grove, 2/F
AI and computational design in drug discovery
10:30
Coffee break
Large-scale datasets to feed future AIs
11:45
What does AI in Longevity Biotech really need?
12:30
Lunch
Targeting neurodegeneration with AI
14:40
Beyond Decline: Next-Generation Targets in Neuroimmune Aging
15:20
Coffee break
AI for systems immunology and immune aging
16:35
Panel discussion and open Q&A
17:20
Closing remarks
October 3 · Saturday · Main Track
Canopy Hall, 3/F
08:00
Breakfast and registration
09:00
Parallel forums at Cedar Grove, 2/F
09:00
Chair Opening Introduction
10:15
Search & Evaluation Strategies for Longevity Therapeutics
11:00
Morning networking break and group photo
11:30
Metabolic health and longevity symposium by Nestlé Research
12:30
Lunch break
13:30
Aging research in pharma
14:10
Therapeutic Assets & Licensing (Late Stage)
15:30
Afternoon networking break and poster session
16:00
Therapeutic Assets & Licensing (Early Stage)
18:40
Closing remarks
7
01
October · Thursday
Main Track · Canopy Hall, 3/F
David Rubenstein Treehouse
at Harvard University
at Harvard University
08:00–09:00
Breakfast and registration
09:00–09:10
Opening
George Daley
Dean · Harvard Medical School
09:10–09:20
Chair Opening Introduction
Evelyne Bischof
Professor · Sheba Medical Center
Alex Zhavoronkov
CEO · Insilico Medicine
Vadim Gladyshev
Professor · Harvard Medical School
Morten Scheibye-Knudsen
Professor · University of Copenhagen
Jesse Poganik
Instructor · Harvard Medical School
09:20–09:30
Jamie Justice
Executive Vice President, Health Domain · XPRIZE Healthspan
Talk title TBA
8
Main Track continues on p. 9
01 · Main Track · continued
09:30–09:50
Policy & Regulatory Address
Special guest keynote
Speaker to be announced
09:50–10:00
Clinical trials for aging: how ARPA-H PROSPR is building the train tracks to support a future industry
Andrew Brack
Program Manager, Proactive Health · ARPA-H
Main Track continues on p. 10
9
01 · Main Track · continued
10:00–10:50
Matching Clinical Trials of Therapeutics & Regulatory Mandates
Andrew Brack
moderator
Program Manager, Proactive Health · ARPA-H
Jeffrey Siegel
panelist
Director, Office of Drug Evaluation Sciences, OND, CDER · FDA
Justin Penzenstadler
panelist
Associate Director (Acting) · OCHEN/OND/CDER/FDA
Lowell M. Zeta
panelist
Acting Chief of Staff, Office of the Commissioner · FDA
10:50–11:20
Morning networking break
10
Main Track continues on p. 11
01 · Main Track · continued
11:20–12:00
Clinical Trials in Diseases of Aging: From Evidence to New Therapeutics and Regulatory Pathways
Sebastien Thuault
moderator
Editor · Nature Medicine
Steven Quay
panelist
CEO · Atossa Therapeutics
Jill Lee
panelist
Director, Regulatory Policy & Intelligence · Novo Nordisk
Calum MacRae
panelist
Professor · Mass General Brigham
Christoph Westphal
panelist
General Partner · Longwood Fund
Steve Horvath
panelist
Professor · UCLA
Brian Nahed
panelist
Professor & Vice Chair of Neurosurgery · Mass General Hospital / HMS
12:00–13:00
Lunch break
Main Track continues on p. 12
11
01 · Main Track · continued
13:00–14:00
AI & Clinical Trials in Healthspan
Andrew Shin
moderator
Chief Strategy Officer · Mass General Brigham
13:00–13:20
Elena Bonfiglioli
Global Business Leader, GM Healthcare, Pharma & Life Sciences · Microsoft
Talk title TBA
13:20–13:40
Wei-Wu He
CEO · Human Longevity, Inc.
Talk title TBA
13:40–14:00
Evelyne Bischof
Professor · Sheba Medical Center
Talk title TBA
12
Main Track continues on p. 13
01 · Main Track · continued
14:00–15:00
Healthspan in Leading Industries
Josh Joyner (TBC)
moderator
Editor · Forbes Health
14:00–14:20
Stephanie Manson-Brown
Head of Clinical Development & Scientific Innovation, Skincare R&D · AbbVie
Talk title TBA
14:20–14:40
Laure Crabbe-Vert
Senior Life Science Innovation Manager · LVMH Research
Talk title TBA
14:40–15:00
Philipp Gut
Adult Health Lead, Research Lead Healthy Longevity · Nestlé
Talk title TBA
15:00–15:30
Afternoon networking break and poster session
Poster session at One Milestone
Main Track continues on p. 14
13
01 · Main Track · continued
15:30–16:30
Aging Research and Pharma R&D Productivity
Lisa Melton
moderator
Senior News Editor · Nature Biotechnology
15:30–15:50
Michael Li
Assistant Professor · Harvard Business School
Talk title TBA
15:50–16:10
Alexander Schuhmacher
Professor · Technische Hochschule Ingolstadt
Talk title TBA
16:10–16:30
Michael Ringel
COO · Life Biosciences
Talk title TBA
14
Main Track continues on p. 15
01 · Main Track · continued
16:30–17:30
Clinical Healthspan Trials and Practice
Barbara Cheifet
moderator
Chief Editor · Nature Biotechnology
16:30–16:50
Vishwa Deep Dixit
Professor · Yale School of Medicine
Talk title TBA
16:50–17:10
James Kirkland
Professor · Cedars-Sinai Medical Center
Talk title TBA
17:10–17:30
Nicole Sirotin
CEO · Institute for Healthier Living Abu Dhabi
Talk title TBA
Main Track continues on p. 16
15
01 · Main Track · continued
17:30–18:10
From Healthspan Trials to Clinical Practice: Building the Path to Patient Access
Michael Basson
moderator
Editor · Nature Medicine
David Dodick
panelist
CMO / Professor · Atria Health Institute / Mayo Clinic
Sara Bonnes
panelist
Professor · Mayo Clinic College of Medicine
Erwin Tan
panelist
Senior Director · AARP
18:10–18:20
Closing remarks
18:30–21:00
Open bar
16
02
October · Friday
Main Track · Canopy Hall, 3/F
David Rubenstein Treehouse
at Harvard University
at Harvard University
08:00–09:00
Breakfast and registration
09:00–09:15
Chair Opening Introduction
Alex Zhavoronkov
CEO · Insilico Medicine
Vadim Gladyshev
Professor · Harvard Medical School
Morten Scheibye-Knudsen
Professor · University of Copenhagen
Daniela Bakula
Professor · University of Copenhagen
Jesse Poganik
Instructor · Harvard Medical School
09:15–09:35
Reimagining Drug Discovery Through the Lens of Aging Biology
Fiona Marshall
President, Biomedical Research · Novartis
Main Track continues on p. 18
17
02 · Main Track · continued
09:35–10:20
Pharma Chief Executive Panel
Alice Park
moderator
Senior Health Correspondent · TIME
Christophe Weber
panelist
Ex-CEO · Takeda
Elcin Barker Ergun
panelist
CEO · Menarini
Fiona Marshall
panelist
President, Biomedical Research · Novartis
Ariel Feldstein
panelist
CSO, Internal Medicine · Pfizer
10:20–10:40
Alex Zhavoronkov
CEO · Insilico Medicine
Talk title TBA
10:40–11:00
Kevin Duffin
VP, Aging Research · Eli Lilly
Talk title TBA
11:00–11:30
Morning networking break and group photo
18
Main Track continues on p. 19
02 · Main Track · continued
11:30–12:10
New Technology Partnering & Licensing
Alex Philippidis
moderator
Senior Business Editor · Genetic Engineering & Biotechnology News
Morten Sogaard
panelist
SVP, Head of Astellas Innovation Lab · Astellas
Christopher Austin
panelist
SVP, R&D Technologies · GSK
Alex Cogdill
panelist
Head of Strategic Initiatives, Global Business Development · Daiichi Sankyo
Vishnu Sresht
panelist
Director, Computational Chemistry and Machine Learning · Genentech
12:10–12:30
George Church
Professor · Harvard Medical School
Talk title TBA
12:30–13:30
Lunch break
Main Track continues on p. 20
19
02 · Main Track · continued
13:30–13:50
BioAge – Novartis joint presentation
Speakers to be announced
Talk title TBA
13:50–14:10
Maxwell Biosciences
Speaker to be announced
Talk title TBA
14:10–14:30
Biocytogen
Speaker to be announced
Talk title TBA
14:30–14:50
Tony Wyss-Coray
Professor · Stanford University
Talk title TBA
20
Main Track continues on p. 21
02 · Main Track · continued
14:50–15:30
Diseases as a Pathway to Longevity Therapeutics: Which age-related disease resembles aging most closely?
Barbara Cheifet
moderator
Chief Editor · Nature Biotechnology
Ruth Gimeno
panelist
VP, Diabetes, Obesity & Cardiometabolic Research and Early Clinical Development · Eli Lilly
Ariel Feldstein
panelist
CSO, Internal Medicine · Pfizer
Carine Boustany
panelist
SVP, Global Head of Immunology and Respiratory Diseases · Boehringer Ingelheim
15:30–16:00
Afternoon networking break and poster session
Poster session at One Milestone · ice cream station outside from 15:00
Main Track continues on p. 22
21
02 · Main Track · continued
16:00–16:40
Early Stage Investor Panel
Sergey Jakimov
moderator
Founding and Managing Partner · LongeVC
Arie Belldegrun
panelist
Co-Founder · Bellco Capital
Yan Lei
panelist
CEO · Synaro Capital
Gérôme Guiot
panelist
Strategic Projects Director · LVMH
Chuen Yan Leung
panelist
Partner, Healthcare Investment · Value Partners Group
Amol Pawar
panelist
Executive Director · UBS
22
Main Track continues on p. 23
02 · Main Track · continued
16:40–17:20
Full-Stack and Growth Stage Investor Panel
Patrick Temple-West
moderator
Journalist · Financial Times
Jim Flynn
panelist
Managing Partner · Deerfield
Alfredo Viegas
panelist
Managing Director · Oaktree Capital Management
Murali Venkatesan
panelist
Global Head of Danaher Ventures · Danaher
Carl Gordon
panelist
Managing Partner · OrbiMed
Kan Chen
panelist
Partner · Qiming Venture Partners
17:20–17:40
Kirsten Seale
Scientist · TruDiagnostic
Talk title TBA
17:40–18:00
Marco Quarta
Co-Founder, CSO · Rubedo Life Sciences
Talk title TBA
Main Track continues on p. 24
23
02 · Main Track · continued
18:00–18:20
Adiv Johnson
CSO · Tally Health
Talk title TBA
18:20–18:40
Matthew O’Connor
CEO · Cyclarity Therapeutics
Talk title TBA
18:40–21:00
Open bar
19:00–21:00
Special speaker event
24
02
October · Friday
AI in Drug Discovery Forum · Cedar Grove, 2/F
David Rubenstein Treehouse
at Harvard University
at Harvard University
09:00–09:10
Opening remarks and welcome
AI and computational design in drug discovery
09:10–09:30
Yves Fomekong Nanfack
Head of ML · Takeda
Talk title TBA
09:30–09:50
Alex Zhavoronkov
CEO · Insilico Medicine
Talk title TBA
09:50–10:10
Kia Winslow
Director · BioAge
Talk title TBA
AI in Drug Discovery Forum continues on p. 26
25
02 · AI in Drug Discovery Forum · continued
10:10–10:30
Reproducibility-Aware AI for Drug Discovery: Purrsistence as a Service
Alex Voda
CEO · The Cat Health Company
10:30–10:45
Coffee break
Large-scale datasets to feed future AIs
10:45–11:05
Proteomic Clocks for Target Nomination
Jon Gootenberg
Professor · Harvard
11:05–11:25
Retro Biosciences
Speaker to be announced
Talk title TBA
11:25–11:45
Biomedical Mega Projects for Data Collection in Longevity
Max Unfried
Scientist · National University of Singapore
26
AI in Drug Discovery Forum continues on p. 27
02 · AI in Drug Discovery Forum · continued
11:45–12:30
What does AI in Longevity Biotech really need?
Panel discussion and open Q&A
Anna Skaya
General Partner · AniVC
12:30–13:30
Lunch
13:30–13:40
Opening remarks and welcome
Targeting neurodegeneration with AI
13:40–14:00
AI4Cure-AD platform for Alzheimer’s disease drug development
Feixiong Cheng
Director, Genome Center · Cleveland Clinic
14:00–14:20
DeepDrugX for Alzheimer’s Disease Drug Discovery
Jacqueline Lam
Scholar · University of Cambridge
AI in Drug Discovery Forum continues on p. 28
27
02 · AI in Drug Discovery Forum · continued
14:20–14:40
LLMs to Flip the Script on Neuroimmune Aging Targets
Gerald Lushington
Expert Team Lead · SpaceX / Qnapsyn Biosciences
14:40–15:20
Beyond Decline: Next-Generation Targets in Neuroimmune Aging
Panel discussion and open Q&A
Derek Huffman
Professor, Molecular Pharmacology & Medicine · Albert Einstein College of Medicine
15:20–15:35
Coffee break
AI for systems immunology and immune aging
15:35–15:55
Derya Unutmaz
Professor · Jackson Laboratory for Genomic Medicine
Talk title TBA
28
AI in Drug Discovery Forum continues on p. 29
02 · AI in Drug Discovery Forum · continued
15:55–16:15
David Furman
Professor · Buck Institute
Talk title TBA
16:15–16:35
AI Antibody Design
Debora Marks
Professor · Harvard
16:35–17:20
Panel discussion and open Q&A
Andrea Cipriano
Director of Immunology, Eli Lilly · Adjunct Professor, Stanford School of Medicine
17:20–17:30
Closing remarks
29
03
October · Saturday
Main Track · Canopy Hall, 3/F
David Rubenstein Treehouse
at Harvard University
at Harvard University
08:00–09:00
Breakfast and registration
09:00–17:30
Parallel forums at Cedar Grove, 2/F
Pet and Animal Longevity Forum · Virtual Cell in Time Forum — detailed programme to be announced
09:00–09:15
Chair Opening Introduction
Alex Zhavoronkov
CEO · Insilico Medicine
Vadim Gladyshev
Professor · Harvard Medical School
Morten Scheibye-Knudsen
Professor · University of Copenhagen
Daniela Bakula
Professor · University of Copenhagen
Jesse Poganik
Instructor · Harvard Medical School
09:15–09:35
Jim O’Neill (tentative)
Organisation to be confirmed
Talk title TBA
30
Main Track continues on p. 31
03 · Main Track · continued
09:35–09:55
Vadim Gladyshev
Professor · Harvard Medical School
Talk title TBA
09:55–10:15
Mark Cobbold
SVP, IO Discovery & Cell Therapy Oncology · AstraZeneca
Talk title TBA
10:15–11:00
Search & Evaluation Strategies for Longevity Therapeutics
Lisa Melton
moderator
Senior News Editor · Nature Biotechnology
Thomas Marron
panelist
AVP, Emerging Innovation and Strategic Growth · Eli Lilly
Kaivan Khavandi
panelist
SVP & Global Head, Respiratory, Immunology & Inflammation R&D · GSK
Tala Fakhouri
panelist
Chief AI & Regulatory Strategy Officer · Parexel
Main Track continues on p. 32
31
03 · Main Track · continued
11:00–11:30
Morning networking break and group photo
11:30–12:10
Metabolic health and longevity symposium by Nestlé Research
Panel
Participants to be announced
12:10–12:30
Holistic approach to aging population
Alejandro Aguayo-Orozco
Senior Scientific Director, Diabetes Insights · Novo Nordisk
12:30–13:30
Lunch break
32
Main Track continues on p. 33
03 · Main Track · continued
13:30–14:10
Aging research in pharma
Sebastian Thuault (TBC)
moderator
Editor · Nature Aging
Sophie Lemire-Brachat
panelist
Executive Director, Head of Translational and Data Science, Diseases of Aging and Regenerative Medicine · Novartis
Maria Dermit
panelist
Scientist · Novo Nordisk
Björn Tackenberg
panelist
Head of Integrative Neuroscience · Roche
William Mair
panelist
Professor of Molecular Metabolism · Harvard University
Main Track continues on p. 34
33
03 · Main Track · continued
14:10–14:50
Therapeutic Assets & Licensing (Late Stage)
Cailin McGurk
moderator
Managing Director · Morgan Stanley
Monika Vnuk
panelist
SVP, Global Head of Partnering and Business Development · Sanofi
Phil McGurk
panelist
SVP, Head of Global Business Development · Takeda
14:50–15:10
Martin Borch Jensen
Co-Founder, CSO · Gordian Biotechnology
Talk title TBA
15:10–15:30
Cambrian Bio
Speaker to be announced
Talk title TBA
15:30–16:00
Afternoon networking break and poster session
Poster session at One Milestone · ice cream station outside from 15:00
34
Main Track continues on p. 35
03 · Main Track · continued
16:00–16:40
Therapeutic Assets & Licensing (Early Stage)
Brianna Stubbs
moderator
Research Assistant Professor & Director of Translational Science · Buck Institute for Research on Aging
Jonathan Levi
panelist
Senior Director, R&D Strategy · AstraZeneca
Xingli Wang
panelist
Global Partner · Fosun Pharma
Claris Munksgaard
panelist
Director, Business Development and Licensing · EMD Serono / Merck
Nikolaj Kulahin Roed (TBC)
panelist
Global Project Leader · Novo Nordisk
16:40–17:00
Johan Luthman
EVP, R&D · Lundbeck
Talk title TBA
Main Track continues on p. 36
35
03 · Main Track · continued
17:00–17:20
Tolerance Bio
Speaker to be announced
Talk title TBA
17:20–17:40
Gordan Lauc
Professor · University of Zagreb
Talk title TBA
17:40–18:00
Brian Bodemann
CEO · ARTAN Bio
Talk title TBA
18:00–18:20
David Sinclair
Professor · Harvard Medical School
Talk title TBA
18:20–18:40
Morten Scheibye-Knudsen
Professor · University of Copenhagen
Talk title TBA
36
Main Track continues on p. 37
03 · Main Track · continued
18:40–19:00
Closing remarks
37
Speakers
Alejandro Aguayo-Orozco
Senior Scientific Director, Diabetes Insights · Novo Nordisk
Christopher Austin
SVP, R&D Technologies · GSK
Daniela Bakula
Professor · University of Copenhagen
Michael Basson
Editor · Nature Medicine
Arie Belldegrun
Co-Founder · Bellco Capital
Evelyne Bischof
Professor · Sheba Medical Center
Brian Bodemann
CEO · ARTAN Bio
Elena Bonfiglioli
Microsoft
Sara Bonnes
Professor · Mayo Clinic College of Medicine
Carine Boustany
Boehringer Ingelheim
Andrew Brack
Program Manager, Proactive Health · ARPA-H
Barbara Cheifet
Chief Editor · Nature Biotechnology
Kan Chen
Partner · Qiming Venture Partners
Feixiong Cheng
Director, Genome Center · Cleveland Clinic
George Church
Professor · Harvard Medical School
Andrea Cipriano
Adjunct Professor, Stanford School of Medicine
Mark Cobbold
SVP, IO Discovery & Cell Therapy Oncology · AstraZeneca
Alex Cogdill
Daiichi Sankyo
Laure Crabbe-Vert
Senior Life Science Innovation Manager · LVMH Research
George Daley
Dean · Harvard Medical School
Maria Dermit
Scientist · Novo Nordisk
Vishwa Deep Dixit
Professor · Yale School of Medicine
David Dodick
CMO / Professor · Atria Health Institute / Mayo Clinic
Kevin Duffin
VP, Aging Research · Eli Lilly
Elcin Barker Ergun
CEO · Menarini
Tala Fakhouri
Chief AI & Regulatory Strategy Officer · Parexel
Ariel Feldstein
CSO, Internal Medicine · Pfizer
Jim Flynn
Managing Partner · Deerfield
David Furman
Professor · Buck Institute
Ruth Gimeno
Eli Lilly
Vadim Gladyshev
Professor · Harvard Medical School
Jon Gootenberg
Professor · Harvard
Carl Gordon
Managing Partner · OrbiMed
Gérôme Guiot
Strategic Projects Director · LVMH
Philipp Gut
Adult Health Lead, Research Lead Healthy Longevity · Nestlé
Wei-Wu He
CEO · Human Longevity, Inc.
38
Speakers · continued
Steve Horvath
Professor · UCLA
Derek Huffman
Albert Einstein College of Medicine
Sergey Jakimov
Founding and Managing Partner · LongeVC
Martin Borch Jensen
Co-Founder, CSO · Gordian Biotechnology
Adiv Johnson
CSO · Tally Health
Josh Joyner (TBC)
Editor · Forbes Health
Jamie Justice
Executive Vice President, Health Domain · XPRIZE Healthspan
Kaivan Khavandi
GSK
James Kirkland
Professor · Cedars-Sinai Medical Center
Jacqueline Lam
Scholar · University of Cambridge
Gordan Lauc
Professor · University of Zagreb
Jill Lee
Director, Regulatory Policy & Intelligence · Novo Nordisk
Yan Lei
CEO · Synaro Capital
Sophie Lemire-Brachat
Novartis
Chuen Yan Leung
Partner, Healthcare Investment · Value Partners Group
Jonathan Levi
Senior Director, R&D Strategy · AstraZeneca
Michael Li
Assistant Professor · Harvard Business School
Gerald Lushington
Expert Team Lead · SpaceX / Qnapsyn Biosciences
Johan Luthman
EVP, R&D · Lundbeck
Calum MacRae
Professor · Mass General Brigham
William Mair
Professor of Molecular Metabolism · Harvard University
Stephanie Manson-Brown
AbbVie
Debora Marks
Professor · Harvard
Thomas Marron
AVP, Emerging Innovation and Strategic Growth · Eli Lilly
Fiona Marshall
President, Biomedical Research · Novartis
Cailin McGurk
Managing Director · Morgan Stanley
Phil McGurk
SVP, Head of Global Business Development · Takeda
Lisa Melton
Senior News Editor · Nature Biotechnology
Claris Munksgaard
EMD Serono / Merck
Brian Nahed
Mass General Hospital / HMS
Yves Fomekong Nanfack
Head of ML · Takeda
Matthew O’Connor
CEO · Cyclarity Therapeutics
Jim O’Neill (tentative)
Organisation to be confirmed
Alice Park
Senior Health Correspondent · TIME
Amol Pawar
Executive Director · UBS
Justin Penzenstadler
Associate Director (Acting) · OCHEN/OND/CDER/FDA
39
Speakers · continued
Alex Philippidis
Genetic Engineering & Biotechnology News
Jesse Poganik
Instructor · Harvard Medical School
Marco Quarta
Co-Founder, CSO · Rubedo Life Sciences
Steven Quay
CEO · Atossa Therapeutics
Michael Ringel
COO · Life Biosciences
Nikolaj Kulahin Roed (TBC)
Global Project Leader · Novo Nordisk
Morten Scheibye-Knudsen
Professor · University of Copenhagen
Alexander Schuhmacher
Professor · Technische Hochschule Ingolstadt
Kirsten Seale
Scientist · TruDiagnostic
Andrew Shin
Chief Strategy Officer · Mass General Brigham
Jeffrey Siegel
Director, Office of Drug Evaluation Sciences, OND, CDER · FDA
David Sinclair
Professor · Harvard Medical School
Nicole Sirotin
CEO · Institute for Healthier Living Abu Dhabi
Anna Skaya
General Partner · AniVC
Morten Sogaard
SVP, Head of Astellas Innovation Lab · Astellas
Vishnu Sresht
Genentech
Brianna Stubbs
Buck Institute for Research on Aging
Björn Tackenberg
Head of Integrative Neuroscience · Roche
Erwin Tan
Senior Director · AARP
Patrick Temple-West
Journalist · Financial Times
Sebastian Thuault (TBC)
Editor · Nature Aging
Sebastien Thuault
Editor · Nature Medicine
Max Unfried
Scientist · National University of Singapore
Derya Unutmaz
Professor · Jackson Laboratory for Genomic Medicine
Murali Venkatesan
Global Head of Danaher Ventures · Danaher
Alfredo Viegas
Managing Director · Oaktree Capital Management
Monika Vnuk
Sanofi
Alex Voda
CEO · The Cat Health Company
Xingli Wang
Global Partner · Fosun Pharma
Christophe Weber
Ex-CEO · Takeda
Christoph Westphal
General Partner · Longwood Fund
Kia Winslow
Director · BioAge
Tony Wyss-Coray
Professor · Stanford University
Lowell M. Zeta
Acting Chief of Staff, Office of the Commissioner · FDA
Alex Zhavoronkov
CEO · Insilico Medicine
40
Practical information
Venue
David Rubenstein Treehouse
20 Western Avenue, Allston, Massachusetts
Canopy Hall 3/F · Cedar Grove 2/F
20 Western Avenue, Allston, Massachusetts
Canopy Hall 3/F · Cedar Grove 2/F
Contact
General enquiries · ardd@pharma.ai
Media and sponsorship · ardd@pharma.ai
Media and sponsorship · ardd@pharma.ai
Online
Live programme · agingpharma.org/program2026
Speakers · agingpharma.org/speakers2026
Registration · agingpharma.org/registration
Location · agingpharma.org/location
Speakers · agingpharma.org/speakers2026
Registration · agingpharma.org/registration
Location · agingpharma.org/location
Conduct and safety
Code of conduct · agingpharma.org/codeofconduct
Scam warning · agingpharma.org/warning
Scam warning · agingpharma.org/warning
The programme is subject to change. The live programme page carries the current schedule.
41
Sponsors and partners
Tier 1
Insilico Medicine
Eli Lilly
Tier 3
AstraZeneca
AbbVie
Human Longevity
Nestlé
Dior
Maxwell Biosciences
BioAge Labs
Gordian Biotechnology
GlycanAge
LongeVC
AniVC
Tolerance Bio
Tally Health
Institute for Healthier Living Abu Dhabi
Cambrian Bio
Biocytogen
TruDiagnostic
Cyclarity Therapeutics
XPRIZE Healthspan
ARTAN Bio
BIO
Rubedo Life Sciences
42
Tier 4
Synaro Capital
The Cat Health Company
PranaGen Bioscience
Life Biosciences
Biointron
Einstein BIO-VITAL Program
Shift Bioscience
Tier 5
Morgan Stanley
Estée Lauder Companies
Intrinsic Capacity, Frailty & Sarcopenia Research Conference for Healthy Longevity
quadraScope
Retro Biosciences
BrainKey
Compound Life
Supporting organizations
43
ARDD
2026
2026
agingpharma.org
ardd@pharma.ai
ardd@pharma.ai